Ilaria Maugeri
Overview
Explore the profile of Ilaria Maugeri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ligorio F, Vingiani A, Torelli T, Sposetti C, Drufuca L, Iannelli F, et al.
Cell Metab
. 2024 Dec;
37(2):330-344.e7.
PMID: 39694040
In preclinical experiments, cyclic fasting-mimicking diets (FMDs) showed broad anticancer effects in combination with chemotherapy. Among different tumor types, triple-negative breast cancer (TNBC) is exquisitely sensitive to FMD. However, the...
2.
Colciago R, La Rocca E, Giandini C, Carnevale M, Bianchi G, Maugeri I, et al.
Tumori
. 2024 Oct;
110(6):451-461.
PMID: 39450849
Purpose: This study aimed to compare the incidence of fat necrosis after accelerated partial breast irradiation (APBI) vs hypofractionated whole breast irradiation (WBI) in patients with early-stage breast cancer. Materials...
3.
Lissidini G, Nicosia L, Sargenti M, Cucchi M, Fabi A, Falco G, et al.
Breast Cancer Res Treat
. 2024 Jun;
208(1):29-40.
PMID: 38896332
Introduction: To offer an extensive retrospective experience on the management of male breast cancer. Methods: A multicenter retrospective observational cohort study was conducted, including male patients diagnosed with breast cancer...
4.
Depretto C, Della Pepa G, De Berardinis C, Suman L, Ferranti C, Marchesini M, et al.
Clin Breast Cancer
. 2023 Sep;
23(8):e491-e498.
PMID: 37704563
Introduction: For decades the standard for preoperative breast lesions' localization has been wire localization. In recent years the options for nonwired localization have significantly expanded and include radioactive seeds, radar...
5.
Gennaro M, Maccauro M, Mariani L, Listorti C, Sigari C, De Vivo A, et al.
Cancer
. 2022 Oct;
128(24):4185-4193.
PMID: 36259883
Background: The need for axillary dissection (AD) is declining, but it is still essential for many patients with nodal involvement who risk developing breast-cancer-related lymphedema (BCRL) with lifelong consequences. Previous...
6.
Gennaro M, Listorti C, Mariani L, Maccauro M, Bianchi G, Capri G, et al.
Eur J Surg Oncol
. 2020 Nov;
47(7):1606-1610.
PMID: 33160781
Introduction: Although the need for axillary lymph node dissection (AD) is decreasing in breast cancer patients, it remains necessary in some cases. Axillary reverse mapping (ARM) enables the detection of...
7.
Martelli G, Barretta F, Miceli R, Folli S, Maugeri I, Listorti C, et al.
Ann Surg
. 2020 Oct;
276(5):e544-e552.
PMID: 33065651
Objective: To ascertain, in cN0/1 breast cancer patients given primary chemotherapy followed by sentinel node biopsy (SNB), whether SNB alone is adequate axillary treatment if the sentinel nodes (SNs) are...
8.
Lozza L, Fariselli L, Sandri M, Rampa M, Pinzi V, De Santis M, et al.
Radiat Oncol
. 2018 Mar;
13(1):49.
PMID: 29566762
Background: Local recurrences after breast conserving treatment are mainly close to the original tumor site, and as such shorter fractionation strategies focused on and nearest mammary gland, i.e. accelerated partial...
9.
Agresti R, Sandri M, Gennaro M, Bianchi G, Maugeri I, Rampa M, et al.
Clin Breast Cancer
. 2017 Jan;
17(3):219-231.
PMID: 28087389
Background: Nipple-areola complex-sparing mastectomy (NSM), extending the concept of skin-sparing mastectomy, allows for the provision of a better cosmetic result. Large operable T2-T3 breast cancer might theoretically appear suitable for...
10.
Crippa F, Agresti R, Sandri M, Mariani G, Padovano B, Alessi A, et al.
Eur J Nucl Med Mol Imaging
. 2015 Feb;
42(6):818-30.
PMID: 25673053
Purpose: We evaluated whether (18)F-3'-deoxy-3'-fluorothymidine positron emission tomography (FLT PET) can predict the final postoperative histopathological response in primary breast cancer after the first cycle of neoadjuvant chemotherapy (NCT). Methods:...